Adamis pharmaceuticals schedules fourth quarter and full year 2021 financial results conference call and business update

San diego, march 24, 2022 (globe newswire) -- adamis pharmaceuticals corporation (nasdaq: admp), a biopharmaceutical company developing and commercializing specialty products for allergy, opioid overdose, respiratory and inflammatory disease, today announced that it will host an investor conference call on thursday, march 31, 2022 at 2 p.m. pacific time to discuss its financial and operating results for the fourth quarter and full year 2021 as well as provide a business update. the company's press release concerning its fourth quarter and 2021 financial results is expected to be available after 1 p.m. pacific time on march 31, 2022, and on its website. the company also expects to file its annual report on form 10-k for the year ended december 31, 2021 on that date.
ADMP Ratings Summary
ADMP Quant Ranking